Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial"

NCT04123444 is registered in ClinicalTrials.gov with Jakob Stensballe, MD, PhD as lead sponsor.

NCT NCT04123444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04123444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of 72-hour Infusion of Prostacyclin (1 Nanogram(ng)/Kilo(kg)/Minute(Min)) in Patients With Septic Shock Induced Endotheliopathy - a Multicentre Randomized, Placebo-controlled, Blinded, Investigator-initiated Trial"
Lead sponsor
Jakob Stensballe, MD, PhD
Phase
Phase 2/3
Overall status
Completed
Start date
October 30, 2019
Completion date
June 28, 2022
Enrollment
279 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock